First-Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. PregnanciesSteven T. Bird, Ira Krefting, Elnara Fazio‐Eynullayeva et al.|Radiology|2019Cited by 56
Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancyAlmut G. Winterstein, Sonja A. Rasmussen, Thuy Nhu Thai et al.|American Journal of Obstetrics and Gynecology|2022Cited by 42